Relay Therapeutics, Inc. - Common Stock, par value $0.001 per share (RLAY)

CUSIP: 75943R102

Q4 2022 13F Holders as of 31 Dec 2022

Holder snapshot 7 signals
Share change
+4,730,717
Put/Call ratio
0.2%
SEC-reported price per share
$14.94
Number of holders
163
Value change
+$58,936,160
Number of buys
102
Open additional details 1 more signal available
Number of sells
55
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
4,389,099

Security key

75943R102

Report period

Q4 2022

Institutions

163

Top holders

10

Ownership snapshot

Top reported holders of RLAY - Relay Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
SB INVESTMENT ADVISERS (U...
Disclosed value leader
SB INVESTMENT ADVISERS (U...
Comparable rows
15/15
Latest evidence
30 Sep 2022
13F Lead comparable stake: 636% Showing 1-6 of 15 holder rows.

Quick read

SB INVESTMENT ADVISERS (UK) LTD leads the comparable SEC ownership view at 636%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens SB INVESTMENT ADVISERS (UK) LTD's linked filing trail.
Comparable ownership Top 5
SB INVESTMENT ADVISERS (UK) LTD 636%
FMR LLC 272%
VANGUARD GROUP INC 190%
BlackRock Finance, Inc. 154%
JPMORGAN CHASE & CO 114%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
SB INVESTMENT ADVISERS (UK) LTD
13F
Company
13F
636%
$624,234,000
27,904,963 shares
30 Sep 2022
FMR LLC
13F
Company
13F
272%
$267,505,000
11,958,212 shares
30 Sep 2022
VANGUARD GROUP INC
13F
Company
13F
190%
$187,003,000
8,359,520 shares
30 Sep 2022
BlackRock Finance, Inc.
13F
Company
13F
154%
$151,169,000
6,757,637 shares
30 Sep 2022
JPMORGAN CHASE & CO
13F
Company
13F
114%
$112,263,000
5,018,487 shares
30 Sep 2022
Casdin Capital, LLC
13F
Company
13F
107%
$104,768,000
4,683,432 shares
30 Sep 2022
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
163
Shares
128,192,171
Rows available
163
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2022 vs Q3 2022 Across Filers

Q3 2022 holders
153
Q4 2022 holders
163
Holder diff
10
Investor Q3 2022 Shares Q4 2022 Shares Share Diff Share Chg % Q3 2022 value Q4 2022 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .